RU2021111632A - AZITHROMYCIN AND ROXYTHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS - Google Patents
AZITHROMYCIN AND ROXYTHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS Download PDFInfo
- Publication number
- RU2021111632A RU2021111632A RU2021111632A RU2021111632A RU2021111632A RU 2021111632 A RU2021111632 A RU 2021111632A RU 2021111632 A RU2021111632 A RU 2021111632A RU 2021111632 A RU2021111632 A RU 2021111632A RU 2021111632 A RU2021111632 A RU 2021111632A
- Authority
- RU
- Russia
- Prior art keywords
- tpp
- derivative
- senolytic
- following
- analog
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N Azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title claims 14
- 229960004099 azithromycin Drugs 0.000 title claims 6
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 claims 31
- 230000001225 therapeutic Effects 0.000 claims 18
- 239000003795 chemical substances by application Substances 0.000 claims 14
- RXZBMPWDPOLZGW-XMRMVWPWSA-N Roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 13
- LJVAJPDWBABPEJ-PNUFFHFMSA-N Telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 claims 13
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 12
- -1 cyclic alkane Chemical class 0.000 claims 12
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 10
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical class CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 claims 10
- 210000004027 cells Anatomy 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 239000012528 membrane Substances 0.000 claims 8
- 235000021360 Myristic acid Nutrition 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 6
- 150000004666 short chain fatty acids Chemical class 0.000 claims 6
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 claims 5
- KUCQYCKVKVOKAY-CTYIDZIISA-N 2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione Chemical compound C1([C@H]2CC[C@@H](CC2)C2=C(C(C3=CC=CC=C3C2=O)=O)O)=CC=C(Cl)C=C1 KUCQYCKVKVOKAY-CTYIDZIISA-N 0.000 claims 5
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims 5
- QUIJNHUBAXPXFS-XLJNKUFUSA-N Bedaquiline Chemical compound C1([C@H](C2=CC3=CC(Br)=CC=C3N=C2OC)[C@@](O)(CCN(C)C)C=2C3=CC=CC=C3C=CC=2)=CC=CC=C1 QUIJNHUBAXPXFS-XLJNKUFUSA-N 0.000 claims 5
- YBHILYKTIRIUTE-UHFFFAOYSA-N Berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims 5
- 229940093265 Berberine Drugs 0.000 claims 5
- WHTVZRBIWZFKQO-UHFFFAOYSA-N Chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 claims 5
- 229960003677 Chloroquine Drugs 0.000 claims 5
- 229960004475 Chlortetracycline Drugs 0.000 claims 5
- 239000004099 Chlortetracycline Substances 0.000 claims 5
- FMTDIUIBLCQGJB-SEYHBJAFSA-N Demeclocycline Chemical compound C1([C@@H](O)[C@H]2C3)=C(Cl)C=CC(O)=C1C(=O)C2=C(O)[C@@]1(O)[C@@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FMTDIUIBLCQGJB-SEYHBJAFSA-N 0.000 claims 5
- 229960003722 Doxycycline Drugs 0.000 claims 5
- UWKQSNNFCGGAFS-XIFFEERXSA-N Irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 5
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims 5
- MHIGBKBJSQVXNH-IWVLMIASSA-N Metacycline Chemical compound C=C([C@H]1[C@@H]2O)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O MHIGBKBJSQVXNH-IWVLMIASSA-N 0.000 claims 5
- 229960004023 Minocycline Drugs 0.000 claims 5
- DYKFCLLONBREIL-KVUCHLLUSA-N Minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 claims 5
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N Niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 claims 5
- 229960001920 Niclosamide Drugs 0.000 claims 5
- 239000005642 Oleic acid Substances 0.000 claims 5
- 229960000625 Oxytetracycline Drugs 0.000 claims 5
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 5
- 239000004100 Oxytetracycline Substances 0.000 claims 5
- 235000021314 Palmitic acid Nutrition 0.000 claims 5
- SEBFKMXJBCUCAI-HKTJVKLFSA-N Silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims 5
- 229950000628 Silibinin Drugs 0.000 claims 5
- QFJCIRLUMZQUOT-HPLJOQBZSA-N Sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 5
- 235000021355 Stearic acid Nutrition 0.000 claims 5
- 229960002180 Tetracycline Drugs 0.000 claims 5
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 claims 5
- 239000004098 Tetracycline Substances 0.000 claims 5
- FPZLLRFZJZRHSY-HJYUBDRYSA-N Tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 claims 5
- 229930003268 Vitamin C Natural products 0.000 claims 5
- 229960003159 atovaquone Drugs 0.000 claims 5
- 229960000508 bedaquiline Drugs 0.000 claims 5
- 229930015400 berberine Natural products 0.000 claims 5
- 229940074360 caffeic acid Drugs 0.000 claims 5
- QAIPRVGONGVQAS-DUXPYHPUSA-N caffeic acid Natural products OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims 5
- 235000004883 caffeic acid Nutrition 0.000 claims 5
- 235000019365 chlortetracycline Nutrition 0.000 claims 5
- 229960002398 demeclocycline Drugs 0.000 claims 5
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 claims 5
- 229960004768 irinotecan Drugs 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 5
- 229960003494 metacycline Drugs 0.000 claims 5
- 235000021313 oleic acid Nutrition 0.000 claims 5
- 235000019366 oxytetracycline Nutrition 0.000 claims 5
- 229960005224 roxithromycin Drugs 0.000 claims 5
- 235000014899 silybin Nutrition 0.000 claims 5
- 229960002930 sirolimus Drugs 0.000 claims 5
- 229960003787 sorafenib Drugs 0.000 claims 5
- 239000008117 stearic acid Substances 0.000 claims 5
- 229960003250 telithromycin Drugs 0.000 claims 5
- 235000019364 tetracycline Nutrition 0.000 claims 5
- 229960004089 tigecycline Drugs 0.000 claims 5
- 235000019154 vitamin C Nutrition 0.000 claims 5
- 239000011718 vitamin C Substances 0.000 claims 5
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- PJPGMULJEYSZBS-VZFHVOOUSA-N Valienol Chemical compound OCC1=C[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O PJPGMULJEYSZBS-VZFHVOOUSA-N 0.000 claims 4
- 201000004384 alopecia Diseases 0.000 claims 4
- WOVKYSAHUYNSMH-RRKCRQDMSA-N Bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 claims 3
- 229950004398 Broxuridine Drugs 0.000 claims 3
- 230000000926 neurological Effects 0.000 claims 3
- 241001120493 Arene Species 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 206010003246 Arthritis Diseases 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 2
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 2
- 208000002177 Cataract Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 206010061246 Intervertebral disc degeneration Diseases 0.000 claims 2
- 208000001083 Kidney Disease Diseases 0.000 claims 2
- 208000009856 Lung Disease Diseases 0.000 claims 2
- 206010028289 Muscle atrophy Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 150000001299 aldehydes Chemical class 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 2
- 150000001345 alkine derivatives Chemical class 0.000 claims 2
- 231100000360 alopecia Toxicity 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 201000001320 atherosclerosis Diseases 0.000 claims 2
- 235000010233 benzoic acid Nutrition 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical class CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 230000003676 hair loss Effects 0.000 claims 2
- 150000002390 heteroarenes Chemical class 0.000 claims 2
- 200000000018 inflammatory disease Diseases 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 230000020763 muscle atrophy Effects 0.000 claims 2
- 201000000585 muscular atrophy Diseases 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 108009000409 Autophagy Proteins 0.000 claims 1
- 206010057668 Cognitive disease Diseases 0.000 claims 1
- 208000002780 Macular Degeneration Diseases 0.000 claims 1
- 210000002161 Motor Neurons Anatomy 0.000 claims 1
- 206010061536 Parkinson's disease Diseases 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 229940098465 Tincture Drugs 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 150000001344 alkene derivatives Chemical class 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000003712 anti-aging Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 1
- 230000002886 autophagic Effects 0.000 claims 1
- 230000006877 autophagy Effects 0.000 claims 1
- 238000004166 bioassay Methods 0.000 claims 1
- 125000003178 carboxy group Chemical class [H]OC(*)=O 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 230000030833 cell death Effects 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 230000003833 cell viability Effects 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 230000034659 glycolysis Effects 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 150000004947 monocyclic arenes Chemical class 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000002829 reduced Effects 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
Claims (62)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/740,137 | 2018-10-02 | ||
US62/750,559 | 2018-10-25 | ||
US62/788,187 | 2019-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2021111632A true RU2021111632A (en) | 2022-11-11 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102316932B (en) | Methods of treating hair related conditions | |
JP6584494B2 (en) | Method for inhibiting HMGB1 activation of melanin producing cells, and method for identifying a drug suitable for such inhibition | |
Zöller et al. | Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model | |
EP3126831A1 (en) | Method for screening trp channels | |
JP2022504204A (en) | Azithromycin and roxithromycin derivatives as aging cell death inducers | |
JP2012152127A (en) | Skin barrier function recovering agent | |
Nair et al. | Development and evaluation of plumbagin loaded chitin hydrogel for the treatment of skin cancer | |
RU2021111632A (en) | AZITHROMYCIN AND ROXYTHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS | |
WO2012144080A1 (en) | Skin barrier function improving agent | |
Yeom et al. | 2, 3, 5, 6-Tetramethylpyrazine of Ephedra sinica regulates melanogenesis and inflammation in a UVA-induced melanoma/keratinocytes co-culture system | |
Choi et al. | Effect of tape stripping on percutaneous penetration and topical vaccination | |
JP5392742B2 (en) | Melanin production inhibitor | |
Ciurlea et al. | A comparative study regarding melanoma activity of betulinic acid on topical ointment vs. systemic nanoemulsion delivery systems | |
Tang et al. | Investigation of β-caryophyllene as terpene penetration enhancer: Role of stratum corneum retention | |
US20160067211A1 (en) | Pharmaceutical composition | |
KR101969229B1 (en) | Kit for treating osteoarthritis with alleviating pain | |
CN116077359A (en) | Use of tretinoin receptor agonist compounds in cosmetic compositions | |
Mejía-Valdez et al. | Potential Role of Oleanolic and Ursolic Acids from Food and Plant Materials as Natural Ingredients for the Cosmetic Industry: A Review | |
JP6656890B2 (en) | Filaggrin production promoter | |
KR20200052947A (en) | How to promote hair growth using valproic acid | |
JPWO2020072598A5 (en) | ||
JP7325234B2 (en) | Evaluation method of degree of skin aging | |
JPH0733624A (en) | Agent for treating and preventing acne | |
Kasahara et al. | A study on the mechanisms and the efficacy of the anti-wrinkle ingredient NEI-L1 | |
Arpaci et al. | Evaluation of biocompability of supramolecular calixarene on L-929 by real time cell analysis |